This division covers R&D directed towards human health, including the understanding
and treatment of clinical diseases and conditions and the provision of public health
and associated support services.
a) Development of pharmaceutical products to treat diseases and abnormal conditions
is included in Group 2408 Human pharmaceutical products. b) Community services not directly impacting on health are included in Group 2301
Community services. c) Workplace safety is included in Group 2305 Work and labour market. d) Quarantine and control measures to prevent the entry of diseases into the country
are included in Division 18 Environmental management. e) Health pertaining to Indigenous communities is included in Division 21 Indigenous.